Hexavest’s AbbVie ABBV Stock Holding History

Hexavest’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-21,960	Closed	-$1.39M	–	490
2016 Q3	$1.39M	Hold	21,960	–	–	0.02%	223
2016 Q2	$1.36M	Hold	21,960	–	–	0.02%	236
2016 Q1	$1.25M	Hold	21,960	–	–	0.02%	227
2015 Q4	$1.3M	Sell	21,960 -5,530	-20%	-$319K	0.02%	223
2015 Q3	$1.5M	Hold	27,490	–	–	0.03%	216
2015 Q2	$1.85M	Sell	27,490 -577,321	-95%	-$37.7M	0.03%	216
2015 Q1	$35.4M	Sell	604,811 -27,767	-4%	-$1.68M	0.56%	54
2014 Q4	$41.4M	Sell	632,578 -125,199	-17%	-$7.89M	0.62%	47
2014 Q3	$43.8M	Sell	757,777 -3,019	-0.4%	-$168K	0.67%	44
2014 Q2	$42.9M	Buy	760,796 +13,270	+2%	+$696K	0.64%	50
2014 Q1	$38.4M	Sell	747,526 -8,210	-1%	-$415K	0.6%	48
2013 Q4	$39.9M	Buy	755,736 +1,412	+0.2%	+$69.4K	0.61%	44
2013 Q3	$33.7M	Sell	754,324 -26,007	-3%	-$1.15M	0.51%	55
2013 Q2	$32.3M	Buy	+780,331	New	+$34.1M	0.55%	53

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Hexavest's ABBV Position: Q4 2016 in Review

Hexavest sold out of AbbVie (ABBV) in Q4 2016, closing a stake of 21,960 shares — an estimated $1.39M sold.

Hexavest first reported a position in ABBV in Q2 2013 and held it in 14 quarters. The position peaked at $43.8M in Q3 2014. 1,692 funds tracked by Wall St. Rank hold ABBV as of Q4 2016.

Hexavest reported no remaining AbbVie position as of Q4 2016 after selling out during the quarter.
Hexavest sold 21,960 AbbVie shares in Q4 2016, an estimated $1.39M.
Hexavest first reported a position in AbbVie in Q2 2013 and held it in 14 quarters.
Hexavest's AbbVie position peaked at $43.8M in Q3 2014.
1,692 funds tracked by Wall St. Rank held AbbVie as of Q4 2016.

Based on Hexavest's 13F filing for Q4 2016, filed 12 Jan 2017.